Pictet Asset Management (UK)’s KalVista Pharmaceuticals KALV Stock Holding History

Pictet Asset Management (UK)’s Portfolio KALV Stock Details KALV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$540K	Sell	22,532 -543,197	-96%	-$14.2M	﹤0.01%	1208
2021 Q1	$14.5M	Sell	565,729 -280,820	-33%	-$7.38M	0.02%	572
2020 Q4	$16.1M	Sell	846,549 -7,204	-0.8%	-$124K	0.02%	523
2020 Q3	$10.7M	Buy	853,753 +27,878	+3%	+$349K	0.02%	540
2020 Q2	$9.99M	Buy	825,875 +194,466	+31%	+$2.07M	0.02%	527
2020 Q1	$4.83M	Buy	631,409 +9,039	+1%	+$122K	0.01%	650
2019 Q4	$11.1M	Buy	622,370 +76,895	+14%	+$1M	0.02%	559
2019 Q3	$6.33M	Buy	545,475 +90,989	+20%	+$1.47M	0.01%	653
2019 Q2	$10.1M	Buy	+454,486	New	+$10.7M	0.02%	525

Other funds holding KALV

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Pictet Asset Management (UK)'s KALV Position: Q2 2021 in Review

Pictet Asset Management (UK) reduced its KalVista Pharmaceuticals (KALV) stake by 96% in Q2 2021, selling an estimated $14.2M and leaving 22,532 shares worth $540K. The position accounts for ﹤0.01% of the portfolio, ranked #1208.

Pictet Asset Management (UK) first reported a position in KALV in Q2 2019 and has held it in 9 quarters since. The position peaked at $16.1M in Q4 2020. 110 funds tracked by Wall St. Rank hold KALV as of Q2 2021.

Pictet Asset Management (UK) held 22,532 shares of KalVista Pharmaceuticals worth $540K as of Q2 2021.
Pictet Asset Management (UK) sold 543,197 KalVista Pharmaceuticals shares in Q2 2021, an estimated $14.2M.
KalVista Pharmaceuticals made up ﹤0.01% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #1208 holding.
Pictet Asset Management (UK) first reported a position in KalVista Pharmaceuticals in Q2 2019 and has held it in 9 quarters since.
Pictet Asset Management (UK)'s KalVista Pharmaceuticals position peaked at $16.1M in Q4 2020.
110 funds tracked by Wall St. Rank held KalVista Pharmaceuticals as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.